Adipose Tissue Regulation in HFpEF cell death, growth, fibrosis, and remodeling are regulated. 18, 19 However, much less is known about their role in mediating metabolic cross talk between the heart and the peripheral tissues. 19, 20 In addition to natriuresis, diuresis, and vasodilation, natriuretic peptides released from the heart enhance lipolysis and lipid mobilization. 21, 22 Moreover, it has also been described that these natriuretic peptides induce changes in white AT (WAT) depots promoting the development of brown AT (BAT) characteristics (such as increased thermogenesis and increase energy expenditure), a phenomenon termed browning or beiging. 23 These findings provide further evidence of communication between the heart and the peripheral tissues. However, it is unknown whether cardiokines and the heart may regulate the AT phenotype and biology in nonobese HFpEF. Thus, we sought to investigate whether AT function is regulated in HFpEF in nonobese mice because this may provide mechanistic insight into the relationship between HFpEF and obesity and similarly set the stage for the development of novel treatments for HFpEF.
Methods
A detailed Methods is available in the Data Supplement.
Experimental Model
The Institutional Animal Care and Use Committee at Boston University School of Medicine approved all study procedures related to the handling and surgery of the mice. There were 2 groups of mice experiments.
Eight-week C57BL/6J old mice were anesthetized with 80 to 100 mg/kg ketamine and 5 to 10 mg/kg xylazine intraperitoneally. Mice (20-25 g) underwent uninephrectomy and then received either a continuous infusion of saline (sham) or d-aldosterone (0.30 μg/h; Sigma-Aldrich, St. Louis, MO; HFpEF) for 4 weeks via osmotic minipumps (Alzet; Durect, Cupertino, CA). The animals were euthanized after 4 weeks at which time there was a HFpEF phenotype. 16, 24 Another group of C57BL/6J mice underwent transverse aortic constriction (TAC). Briefly, mice were anesthetized with sodium pentobarbital (50 mg/kg intraperitoneally). The chest was opened, and after blunt dissection through the intercostal muscles, the thoracic aorta was identified. Silk suture (7-0) was placed around the transverse aorta and tied around a 26-gauge blunt needle, which was subsequently removed. Sham-operated mice underwent a similar surgical procedure without aortic constriction. After 14 days, cardiac structure and function were determined by echocardiography. Mice were then euthanized, the hearts were weighed and white adipose depots were collected.
Physiological Measurement
Heart rate and blood pressure (BP) were measured weekly using a noninvasive tail-cuff BP analyzer, BP-2000 Blood Pressure Analysis System (Visitech Systems, Inc., Apex, NC). 16, 24 Transthoracic echocardiography was performed at the end of 4 weeks in chronic aldosterone and after 14 days in TAC using the Vevo 770 High-Resolution In Vivo Micro-Imaging System and a Real-Time Micro Visualization 707B Scanhead (VisualSonic Inc., Toronto, Ontario, Canada), as previously described (further details are available in the Data Supplement). 16 The ratio of wet:dry lung weight ratio was used as an indicator of pulmonary congestion.
Metabolic Measurements and Assessment of Body Composition
Briefly, body composition, including fat mass and lean tissue mass, was measured by noninvasive quantitative magnetic resonance imaging (EchoMRI-700; Echo Medical System, Houston, TX). During the last week of the experiment, mice were subjected to a cold tolerance test (CTT). Glucose tolerance tests and nonfasting blood glucose levels were measured using tail vein blood samples using an Accu-Chek glucometer (Roche Diagnostics Corp, Indianapolis, IN). Details of CTT and glucose tolerance test are available in the Methods in the Data Supplement.
Cell Preparation and Flow Cytometry
Stromal vascular fraction from epididymal WAT was isolated according to Orr's protocol. 25 Cell staining was performed as previously described (Methods in the Data Supplement). 26
Gene Expression Analysis by Quantitative Reverse Transcriptase Polymerase Chain Reaction
Details are available in the Methods and Table I in the Data Supplement.
Western Blot Analysis
Protein extraction and Western blot were performed as previously described (Details are available in the Data Supplement). 16 
Statistical Analysis
Data are shown as mean±SEM unless otherwise stated. Statistical significance of differences between 2 groups was assessed using the Student t tests (2 sided). In those cases when data were not sampled as a normal distribution, nonparametric Mann-Whitney U test was used. Results of glucose tolerance test and CTT experiments were evaluated by 2-way repeated measures ANOVA. P≤0.05 values were considered significant. All statistical tests were performed using GraphPad Prism software (GraphPad Software Inc., La Jolla, CA).
Results

Murine Model of HFpEF
Characteristics and echocardiography parameters are presented in Tables 1 and 2 . Weekly BP and heart rate are shown in Figure IA in the Data Supplement. HFpEF mice demonstrated significantly increased systolic and diastolic BP by the end of 4 weeks of aldosterone infusion. Heart rate was comparable between sham and HFpEF ( Table 1) . LV structure and systolic and diastolic functions are shown in Table 2 . LVEF was preserved, and there was evidence of lung congestion in HFpEF mice (Tables 1 and 2 ). HFpEF mice demonstrated increased LV mass and total wall thickness compared with sham (P<0.001). Similarly, the heart weight:body weight ratio was also increased in HFpEF (P<0.001 versus sham). Although there was a trend to smaller LV cavity size in HFpEF mice, it was not significantly different to sham. Relative wall thickness was increased in HFpEF mice (P<0.01 versus sham). At similar heart rate, HFpEF mice showed severe DD ( Table 2 ). Both mitral E and A velocities were elevated in HFpEF mice (P<0.01 versus sham; Figure II in the Data Supplement). The increased A velocities indicate that LV filling was increasingly dependent on an increase in atrial pressure to drive blood into the LV, during diastole. As early diastolic transmitral pressure gradient increased, early diastolic flow velocities also rose, and the E wave increased, causing the E/A ratio to normalize. Similar to humans, where isovolumic relaxation time initially increases with impaired relaxation but then decreases with progressive worsening of diastolic function, isovolumic relaxation time was significantly shorter (P<0.05 versus Sham), and deceleration time was significantly decreased in HFpEF mice (P<0.001 versus sham). In addition to DD, there was evidence of HF with the preservation of LVEF after 4 weeks of d-aldosterone infusion.
Body Composition, Characteristics, and Glucose Levels
Body weights were comparable between both groups during the 4 weeks of HFpEF induction (Table 1 ; Figure IB in the Data Supplement). Magnetic resonance imaging analysis, performed to assess total lean and fat mass, showed no difference between HFpEF and sham mice ( Figure 1A ). Measurements of WAT weights, however, showed that both epididymal (eWAT) and inguinal (iWAT) adipose depots were significantly smaller in HFpEF mice versus sham (eWAT, 7.59 versus 10.67 mg/g and iWAT, 6.34 versus 8.38 mg/g; Table 1 ; Figure 1B , top and middle). Importantly, there was a relative increase in BAT weight in HFpEF mice versus sham (5.96 versus 4.50 mg/g; P<0.05; Table 1 ; Figure 1B , bottom).
Although there was no evidence of ascites in HFpEF mice, spleen weight was significantly increased in HFpEF versus sham (P<0.001). Similarly, there was a trend toward increased liver mass (P=NS versus sham). Skeletal muscle weight measurement, specifically gastrocnemius muscle, was smaller in HFpEF mice (P<0.05 versus sham). Glucose levels were comparable in both experimental groups under similar nonfasting and fasting conditions ( Table 1 ; Figure 
AT Morphology
To examine whether weight changes in adipose depots were because of morphological alterations, eWAT, iWAT, and BAT histological analysis were performed ( Figure 1B ). HFpEF mice demonstrated significant alterations in WAT morphology. There was a shift to smaller adipocyte size in HFpEF mice in both eWAT (867.91 vs 986.71 μm 2 ; P<0.01) and iWAT (858.43 vs 1006.22 μm 2 ; P<0.05) compared to sham. The smaller adipocytes had multilocular lipid droplets, a typical feature of WAT undergoing beiging or brown-like AT ( Figure 1C ).
Phenotype Switch of AT in HFpEF
We sought to investigate molecular changes that may accompany the morphological changes observed in WAT. There was a marked phenotype switch in eWAT and iWAT in HFpEF mice, with a significant increase in beiging transcripts such as uncoupling protein 1 (ucp-1), cell death-inducing DFFA-like effector a (cidea), and epithelial V-like antigen (eva) by 5-, 2-, and 3-fold, respectively, in eWAT and 9-, 2-, and 3-fold in iWAT (Figure 2A and 2B). Conversely, there was a significant decrease in mRNA levels of typical white adipose markers, such as leptin, resistin, and even adiponectin in the case of eWAT in HFpEF mice (Figure 2A and 2B) .
We next evaluated the molecular phenotype of BAT. Despite the significant increase in BAT weight in HFpEF (Table 1) , there was a marked decrease in expression levels of ucp-1, cidea, and eva (P<0.05 versus sham; Figure 2C ). Furthermore, transcript levels of lipolytic proteins hormonesensitive lipase, lipoprotein lipase, and fatty acid binding protein 4 were all significantly decreased in BAT of HFpEF mice (P<0.05 versus sham; Figure 2C ). Importantly, these changes were also associated with an impaired thermogenic response in HFpEF mice during the CTT ( Figure 2D ). Body temperature was initially the same between groups (37.3°C), but core body temperature dramatically decreased in HFpEF mice after 4 hours of cold (27.8±1.8 versus 34.1±0.8°C; P<0.05 versus sham). Similarly, after only 4 hours of CTT, HFpEF mice had a significant decrease in body weight (−2.1±0.2 versus −1.2±0.2 g; P<0.05 versus sham). These data suggest that BAT function may be decreased or impaired because normal BAT function is expected to improve thermoregulation. We further characterized WAT in HFpEF mice by assessing the inflammatory, fibrotic, and oxidative status in WAT. Recent studies showed changes in the inflammatory response in WAT during beiging and adaptive thermogenesis. 27, 28 Fluorescenceactivated cell sorter analysis of stromal vascular fraction from eWAT revealed significantly increased neutrophil content in HFpEF mice versus sham (6.25×10 2 ±1.2×10 2 versus 1.43×10 2 ±0.36×10 2 ; P<0.05; Figure 3A and 3B). Ly6C high monocytes (proinflammatory function), Ly6C low macrophages (patrolling behavior), and Ki67 + Ly6C low macrophages (macrophage proliferation) were comparable between HFpEF and sham mice. We also analyzed the inflammatory state in iWAT by quantitative reverse transcriptase polymerase chain reaction. Similar to the results obtained in eWAT, there was greater ly6g gene expression (indicating an increase in neutrophil infiltration) in this adipose depot in HFpEF mice (P<0.05 versus sham; Figure 3C ). There were no differences in f4/80, tnfα, and mcp1 transcript expression in iWAT between HFpEF and sham mice ( Figure 3C ). There were also no differences in fibrotic (collagen 1, 3, and 6) and oxidative markers (NAD(P) H subunits p22 phox and p47 phox ) in eWAT or iWAT in HFpEF versus sham mice ( Figure III in the Data Supplement). Similar results were found in BAT ( Figure 3D ; Figure III in the Data Supplement).
Mechanisms Implicated in AT Phenotype Changes
To further investigate beiging activation in WAT during HFpEF, we measured p38 mitogen-activated protein kinase (MAPK) activation in eWAT because it was previously shown that phosphorylation of p38 MAPK can induce UCP-1 protein expression. 23, 29 In eWAT, p38 MAPK phosphorylation was increased by 137±27% in HFpEF when compared with sham mice (P<0.01; Figure 4A ). Furthermore, this increase in p38 MAPK expression was accompanied by an increase in hormone-sensitive lipase phosphorylation in eWAT of HFpEF mice (P<0.05 versus sham; Figure 4B ). With the increase in p38 MAPK activation seen in eWAT, we sought to address the upstream pathway leading to p38 MAPK activation. We first evaluated β3-adrenergic expression, which has been shown to be related to beiging activation. 27, 30 In eWAT of HFpEF mice, β3-receptor protein expression was diminished by −35±7% when compared with sham (P<0.05; Figure 4C ). However, protein kinase A phosphorylation, an important downstream target of the β3-adrenergic pathway, was not altered in eWAT of either HFpEF or sham mice ( Figure 4D ). We sought to determine natriuretic peptide receptors expression in eWAT and BAT. In eWAT, the ratio of gene expression of the natriuretic peptide receptor type A (npra: active form) to natriuretic peptide receptor type C (nrpc: clearance receptor) was increased in HFpEF when compared with sham mice (P=0.001; Figure 4E ), but not different between these groups in BAT (Figure 4F) . These results were also accompanied by an increase in myocardial, LV atrial natriuretic peptide and brain natriuretic peptide expressions by 2.7-and ≈2-fold, respectively, in HFpEF mice, as previously described 16 (P<0.001 and P<0.05, respectively, versus sham; Figure 4G ). To ensure that these findings were not a model-specific finding, ie, an effect of chronic aldosterone, a group of wildtype mice was subjected to TAC or sham procedure. Two weeks after TAC, mice developed HFpEF and showed echocardiographic features consistent with DD ( Table II in the Data  Supplement ) . TAC mice demonstrated higher E velocity and higher E/A ratio consistent with impaired DD. TAC mice had increased LV mass, total wall thickness, and relative wall thickness (P<0.05 versus sham). LVEF was preserved. TAC mice had significantly increased lung congestion (data not shown).
Body weight was comparable in TAC and sham-operated mice (28.16±0.47 versus 27.61±1.09 g; Figure 5A ). WAT weight from TAC was similar to that observed in aldosteroneinfused HFpEF mice ( Figure 5B ). WAT depot had smaller adipocytes ( Figure 5C and 5D ). Moreover, WAT from TAC mice showed elevated transcript levels of ucp-1 (P<0.05) and trends to increase cidea and eva expressions (P=0.07 and P=0.07, respectively). Conversely leptin and resistin expressions were downregulated (P<0.05 and P=0.06, respectively; Figure 5E ). Similarly, the ratio of npra/nprc in WAT was increased in TAC mice (P<0.05 versus sham; Figure 5F ). This was because of increases in npra expression in TAC (data not shown).
Discussion
In this study, we show that HFpEF is associated with changes in AT in nonoverweight mice. Aldosterone-infused mice developed hypertension, LV hypertrophy, DD, and lung congestion, while maintaining a preserved LVEF, thus resulting in HFpEF. 15, 16, 24 Similar changes were seen in TAC-induced HFpEF. There were no changes in total body weight or modifications in total lean and fat mass. However, there was a shift in WAT and BAT weight, with a marked decrease in white adipose depots, whereas the brown depot was significantly increased. The macroscopic decrease of WAT mass was associated with a reduction in adipocyte size in both visceral (eWAT) and subcutaneous (iWAT) AT. The smaller adipocyte size in WAT was associated with the presence of brown-like structures, islets composed of small adipocytes with large nuclei and multilocular cytoplasm. Clusters of UCP-expressing adipocytes have been shown to develop in WAT in response to various stimuli such as sympathetic activation. 30 These adipocytes have been named beige or brite (brown-in-white). Similar to adipocytes in BAT, beige cells are defined by their multilocular lipid droplet morphology, high mitochondrial content, and the expression of a core set of brown fat-specific genes (such as ucp-1, cidea, or eva). 31 We showed an increase in these brown-specific markers, in both eWAT and iWAT in HFpEF mice. Furthermore, there was a reduction in classical murine white adipose markers such as leptin, adiponectin, and resistin. 32 Together, these indicate that HFpEF is associated with the activation of beiging in WAT. Similar findings were seen in TAC-induced HFpEF mice.
When HFpEF mice were challenged in a cold tolerance experiment, they showed an ineffective response of shivering thermogenesis. This failure could indicate an inability to maintain shivering, but may also indicate an inadequate function of BAT. 30 BAT, in contrast to bona fide WAT, dissipates energy through uncoupled respiration and heat production (thermogenesis). This is mediated by the major thermogenic factor UCP-1 and can be activated by stimuli, such as cold exposure and adrenergic factors. [33] [34] [35] Although WAT depots possess the capacity to acquire brown fat characteristics in response to thermogenic stimuli, it is more likely that the beiging of WAT observed here is because of increased natriuretic peptides because circulating levels of brain natriuretic peptide and atrial natriuretic peptide are elevated in HF. 2 Analysis of BAT molecular markers also showed a decrease in browning markers that were also accompanied by decreased expression of lipolytic enzymes, such as hormone-sensitive lipase, lipoprotein lipase, and fatp4, which are responsible for AT regulation of lipid breakdown and the generation of free fatty acids. 32 Thus, the effects of the natriuretic peptides on WAT were also associated with alterations in BAT machinery. It seems that functional and molecular changes occurring in active BAT depots are also present in adult humans and can be readily activated when exposed to stimuli, such as mild cold. [34] [35] [36] Beiging of WAT is usually associated with beneficial effects such as an improvement of insulin sensitivity, or amelioration of obesity. 31, 37, 38 However, recent studies suggest that this process may not always be beneficial. Among several such settings, beiging of WAT is thought to be a driver for weight loss during cancer-associated cachexia. 27 In the same way, our data suggest that the activation of beiging in WAT seems to be inadequate in HFpEF. Although we have not proven cause, notably there are parrallel downregulation of the BAT transcripts that are crucial in fuel generation and thermal homeostasis and needs further study.
Interestingly, the changes observed in WAT were not accompanied by significant changes in fibrosis or oxidative stress status as we might expect in response to HFpEF. 39, 40 Notably, neutrophil content was higher in both eWAT and iWAT. Neutrophils are short-lived cells and are recognized as primary effector cells in acute inflammatory responses and participate in the initiation of immune responses and resolution 41 In both obese humans and animal models, neutrophil-derived proteins, such as neutrophil elastase or myeloperoxidase, and markers for neutrophil activation and neutrophil infiltration are increased. [42] [43] [44] Thus, although neutrophils are implicated in the modulation of AT inflammation in the early stages of obesity, their presence in AT in response to a high-fat diet may last ≤90 days. 43 Our results therefore suggest that the onset of immune activation in WAT may be related to ongoing changes, such as continued neutrophil infiltration in WAT, setting the stage for tissue infiltration by other immune cells, such as macrophages.
Several mechanisms are implicated in WAT beiging, including prolonged cold exposure and adrenergic activation, that both converge with p38 MAPK activation, 27, 29 as well as increases in vascular endothelial growth factor. 45, 46 In HFpEF mice, p38 MAPK phosphorylation was increased in WAT, and this increase was associated with an elevation in hormonesensitive lipase phosphorylation, indicating increased AT lipolysis. 28 Adrenergic signaling is classically thought to be the principal activator of thermogenic machinery. Elevated catecholamines increase intracellular cAMP levels via the β3receptor, directly activating cAMP-dependent protein kinase A, which can also phosphorylate kinases in the p38 MAPK pathway. 47 However, in HFpEF mice, there was downregulation of β3-receptor expression and protein kinase A phosphorylation indicating that the β3 pathway was not implicated in the changes observed in our experimental model. It is well known that BAT is densely innervated, and consequently, thermogenesis in this tissue is regulated primarily by adrenergic tone. In contrast, white adipose depots are less extensively innervated, suggesting that alternate pathways may control p38 MAPK activation and subsequent UCP-1 expression. 48 We thus focused on other effectors that could be related to the observed changes. Bordicchia et al 23 showed that cardiac natriuretic peptides mediate beiging in WAT via the p38 MAPK pathway. Similarly, we examined natriuretic peptide receptors in adipose depots and found that the ratio of npra/nprc was increased in eWAT of HFpEF mice indicating increased signaling or decreased clearance, and demonstrating that natriuretic peptides may play a role in p38 MAPK activation. Furthermore, atrial natriuretic peptide and brain natriuretic peptide expression levels, which are primarily synthesized in the heart with increased expression in HFpEF, 16, 40 were increased in the LV from mice with HFpEF. We thus propose that the natriuretic peptides secreted from the heart play an important role in the changes observed in WAT, and this pathway may be a target for drug development in HFpEF. 
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